Claim: NME1 reduces RNA transcript levels in highly metastatic cells and mutations in this gene have been identified.
Evidence: This gene (NME1) was identified because of its reduced mRNA transcript levels in highly metastatic cells. Mutations in this gene have been identified in aggressive neuroblastomas.